Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Health insurer Cigna boosts forecast as COVID costs recede

Published 05/06/2022, 06:39 AM
Updated 05/06/2022, 10:55 AM
© Reuters. Signage for Cigna is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly

© Reuters. Signage for Cigna is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly

By Mrinalika Roy

(Reuters) -Health insurer Cigna Corp (NYSE:CI) raised its annual adjusted profit forecast on Friday, following a decline in COVID-related costs and no sign of pent-up demand for medical procedures that were delayed due to the pandemic.

Shares of the company shot up nearly 5% to $263.7 in early trading, after it also reported first-quarter profit above estimates.

Health insurers came under pressure from volatile medical costs during the pandemic, but some of that was offset by people postponing non-urgent medical procedures.

"We are not seeing any acuity spikes or pent-up demand emerge for things like blood screenings, preventive exams, mammograms, colonoscopy," Chief Financial Officer Brian Evanko said during a post-earnings call.

"Non-COVID shaping up very much in line with what we had been expecting this year."

A drop in COVID testing and treatment costs also helped Cigna report a lower-than-expected medical care ratio (MCR), the amount spent on medical claims versus income from premiums.

Total medical customers of its health plans rose to 17.8 million in the quarter, boosted by growth in U.S. commercial membership.

"Cigna turned in better-than-anticipated operating results for Q1 that allowed management to boost its 2022 outlook a bit, primarily due to strength in its medical insurance operations where its commercial operations really shined for the first time since the pandemic began," said Morningstar analyst Julie Utterback.

The company moderately raised its forecast for 2022 adjusted profit from operations to at least $22.60 per share, from a minimum of $22.40 per share expected earlier.

© Reuters. Signage for Cigna is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly

"Company offers attractive value, especially if COVID-related pressures continue to improve in 2022," Oppenheimer analyst Michael Wiederhorn said in a note.

Excluding special items, Cigna's income from operations was $6.01 per share, above analysts' average estimate of $5.18, according to Refinitiv IBES data.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.